mBio · 2020 · 168 citations · 51 references
Life SciencesMicrobiologyPathobiologyInnate ImmunityMetabolismMicrobial PathogenesisGut MicrobiomeGut MicrobiotaInnate Immune ReceptorsInnate Immune ResponseInnate Immune Signaling PathwaysLiver DiseaseCausal Bacterial SpeciesGut Microbiome BiomarkersGut Microbiota CompositionGut Microbiota DysbiosisMetabolic Disease BiomarkersPathogen Recognition Receptor SignalingPredictive Biomarker DevelopmentPredictive Biomarker Discovery
Recent studies have reported a link between gut microbiota and nonalcoholic fatty liver disease (NAFLD), showing that germfree (GF) mice do not develop metabolic syndromes, including NAFLD. However, the specific bacterial species causing NAFLD, as well as their molecular cross talk with the host for driving liver disease, remain elusive. Here, we found that nonvirulent endotoxin-producing strains of pathogenic species overgrowing in obese human gut can act as causative agents for induction of NAFLD and related metabolic disorders. The cross talk between endotoxin from these specific producers and the host's TLR4 receptor is the most upstream and essential molecular event for inducing all phenotypes in NAFLD and related metabolic disorders. These nonvirulent endotoxin-producing strains of gut pathogenic species overgrowing in human gut may collectively become a predictive biomarker or serve as a novel therapeutic target for NAFLD and related metabolic disorders.
51
Metabolic Endotoxemia Initiates Obesity and Insulin Resistance
Patrice D. Cani, Jacques Amar, Miguel A. Iglesias et al. · Diabetes · 2007 · 6.4K citations · Full text